These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 29117863)

  • 1. RNA-binding activity of TRIM25 is mediated by its PRY/SPRY domain and is required for ubiquitination.
    Choudhury NR; Heikel G; Trubitsyna M; Kubik P; Nowak JS; Webb S; Granneman S; Spanos C; Rappsilber J; Castello A; Michlewski G
    BMC Biol; 2017 Nov; 15(1):105. PubMed ID: 29117863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM25 Enhances the Antiviral Action of Zinc-Finger Antiviral Protein (ZAP).
    Li MM; Lau Z; Cheung P; Aguilar EG; Schneider WM; Bozzacco L; Molina H; Buehler E; Takaoka A; Rice CM; Felsenfeld DP; MacDonald MR
    PLoS Pathog; 2017 Jan; 13(1):e1006145. PubMed ID: 28060952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM25 Binds RNA to Modulate Cellular Anti-viral Defense.
    Sanchez JG; Sparrer KMJ; Chiang C; Reis RA; Chiang JJ; Zurenski MA; Wan Y; Gack MU; Pornillos O
    J Mol Biol; 2018 Dec; 430(24):5280-5293. PubMed ID: 30342007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIM25 Is Required for the Antiviral Activity of Zinc Finger Antiviral Protein.
    Zheng X; Wang X; Tu F; Wang Q; Fan Z; Gao G
    J Virol; 2017 May; 91(9):. PubMed ID: 28202764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Respiratory Syncytial Virus NS 1 Targets TRIM25 to Suppress RIG-I Ubiquitination and Subsequent RIG-I-Mediated Antiviral Signaling.
    Ban J; Lee NR; Lee NJ; Lee JK; Quan FS; Inn KS
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30558248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The E3 Ligase TRIM25 Impairs Apoptotic Cell Death in Colon Carcinoma Cells via Destabilization of Caspase-7 mRNA: A Possible Role of hnRNPH1.
    Nasrullah U; Stanke K; Recknagel V; Bozkurt S; Wurzel P; Gauer S; Imre G; Münch C; Pfeilschifter J; Eberhardt W
    Cells; 2023 Jan; 12(1):. PubMed ID: 36611995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Trim25 in development, disease and RNA metabolism.
    Heikel G; Choudhury NR; Michlewski G
    Biochem Soc Trans; 2016 Aug; 44(4):1045-50. PubMed ID: 27528750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Production by Interfering with TRIM25-Mediated RIG-I Ubiquitination.
    Hu Y; Li W; Gao T; Cui Y; Jin Y; Li P; Ma Q; Liu X; Cao C
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIM25 and its emerging RNA-binding roles in antiviral defense.
    Choudhury NR; Heikel G; Michlewski G
    Wiley Interdiscip Rev RNA; 2020 Jul; 11(4):e1588. PubMed ID: 31990130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity.
    Gack MU; Shin YC; Joo CH; Urano T; Liang C; Sun L; Takeuchi O; Akira S; Chen Z; Inoue S; Jung JU
    Nature; 2007 Apr; 446(7138):916-920. PubMed ID: 17392790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer.
    Wang S; Kollipara RK; Humphries CG; Ma SH; Hutchinson R; Li R; Siddiqui J; Tomlins SA; Raj GV; Kittler R
    Oncotarget; 2016 Oct; 7(40):64921-64931. PubMed ID: 27626314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Small t Antigen of JC Virus Antagonizes RIG-I-Mediated Innate Immunity by Inhibiting TRIM25's RNA Binding Ability.
    Chiang C; Dvorkin S; Chiang JJ; Potter RB; Gack MU
    mBio; 2021 Apr; 12(2):. PubMed ID: 33849980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEDV nucleocapsid antagonizes zinc-finger antiviral protein by disrupting the interaction with its obligate co-factor, TRIM25.
    Chuenchat J; Kardkarnklai S; Narkpuk J; Liwnaree B; Jongkaewwattana A; Jaru-Ampornpan P; Sungsuwan S
    Vet Microbiol; 2024 Apr; 291():110033. PubMed ID: 38432077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ubiquitin ligase TRIM25 inhibits hepatocellular carcinoma progression by targeting metastasis associated 1 protein.
    Zang HL; Ren SN; Cao H; Tian XF
    IUBMB Life; 2017 Oct; 69(10):795-801. PubMed ID: 28861931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human metapneumovirus M2-2 protein inhibits RIG-I signaling by preventing TRIM25-mediated RIG-I ubiquitination.
    Tanaka Y; Morita N; Kitagawa Y; Gotoh B; Komatsu T
    Front Immunol; 2022; 13():970750. PubMed ID: 36045682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of TRIM25 Catalytic Activation in the Antiviral RIG-I Pathway.
    Sanchez JG; Chiang JJ; Sparrer KMJ; Alam SL; Chi M; Roganowicz MD; Sankaran B; Gack MU; Pornillos O
    Cell Rep; 2016 Aug; 16(5):1315-1325. PubMed ID: 27425606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIM25 and DEAD-Box RNA Helicase DDX3X Cooperate to Regulate RIG-I-Mediated Antiviral Immunity.
    Atkinson SC; Heaton SM; Audsley MD; Kleifeld O; Borg NA
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging RNA-binding roles in the TRIM family of ubiquitin ligases.
    Williams FP; Haubrich K; Perez-Borrajero C; Hennig J
    Biol Chem; 2019 Oct; 400(11):1443-1464. PubMed ID: 31120853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paramyxovirus V Proteins Interact with the RIG-I/TRIM25 Regulatory Complex and Inhibit RIG-I Signaling.
    Sánchez-Aparicio MT; Feinman LJ; García-Sastre A; Shaw ML
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29321315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The E3 ubiquitin ligase TRIM25 regulates adipocyte differentiation via proteasome-mediated degradation of PPARγ.
    Lee JM; Choi SS; Lee YH; Khim KW; Yoon S; Kim BG; Nam D; Suh PG; Myung K; Choi JH
    Exp Mol Med; 2018 Oct; 50(10):1-11. PubMed ID: 30323259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.